Aktiesnakken — September 2010
-
nå ja, jeg ved da godt hvad en and betyder, men vidste ikke hvilken del af breaking news der var anden.
-
kunne også være ham her: http://www.youtube.com/watch?v=n-5F_7DwPpo
-
hun er så grineren
-
Genmab A/S (OMX: GEN) offentliggjorde i
dag opmuntrende resultater fra en fase II sikkerheds- og farmakokinetisk
undersøgelse med -
med ofatumumab til behandling af patienter med
recidiverende-remitterende multipel sklerose (RRMS). -
Mht. Genmab nyheden - det skal tages som positivt?
-
Måske ikke vildt kurspåvirkende, men stadig interessatn
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind